These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9238909)

  • 1. Cognitive function in dialysis patients. Case study of the anemic patient.
    Martin-Lester M
    ANNA J; 1997 Jun; 24(3):359-65; quiz 366. PubMed ID: 9238909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case management of the anemic patient: epoetin alfa--focus on cognitive function.
    Corea AL
    ANNA J; 1993 Jun; 20(3):350-3. PubMed ID: 8352632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case study of the anemic patient: epoetin alfa--focus on protocols.
    Kammerer JK
    ANNA J; 1994 Dec; 21(7):440-3. PubMed ID: 7872824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case management of the anemic patient. Epoetin alfa: focus on quality of life.
    Butera E
    ANNA J; 1992 Aug; 19(4):410-1. PubMed ID: 1520032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoetin alfa--focus on optimal hematocrit. Case study of the anemic patient.
    Hendrix WR
    ANNA J; 1996 Feb; 23(1):46-9. PubMed ID: 8702361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoetin alfa--focus on the rehabilitation of dialysis patients. Case study of the anemic patient.
    Martin-Lester M
    ANNA J; 1996 Dec; 23(6):630-3. PubMed ID: 9069794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case management of the anemic patient. Epoetin alfa: focus on inflammation and infection.
    Schardin KE
    ANNA J; 1990 Dec; 17(6):468-9. PubMed ID: 2256731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care outcomes case study: anemia in end-stage renal disease.
    Turco TF
    Am J Health Syst Pharm; 1995 Oct; 52(19 Suppl 4):S19-23. PubMed ID: 8846242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case study of the anemic patient: epoetin alfa--focus on CQI and patient management.
    Kammerer JK
    ANNA J; 1994 Aug; 21(5):282-5. PubMed ID: 8080342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoetin alfa--focus on dialyzability. Case study of the anemic patient.
    Keen ML
    ANNA J; 1995 Dec; 22(6):610-3. PubMed ID: 8633909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.
    Aiello J
    Nephrol Nurs J; 2002 Jun; 29(3):297-300. PubMed ID: 12164081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case management of the anemic patient: epoetin alfa--focus on adequacy of dialysis.
    Erlich L
    ANNA J; 1993 Apr; 20(2):181-4. PubMed ID: 8512376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoetin alfa--focus on patients who are hospitalized. Case study of the anemic patient.
    Chambers JK
    ANNA J; 1996 Oct; 23(5):508-11. PubMed ID: 9069780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoetin alfa: focus on inflammation and infection. Case study of the anemic patient.
    Chambers JK
    ANNA J; 1998 Jun; 25(3):353-6. PubMed ID: 9801493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

  • 17. Case management of the anemic patient. Epoetin alfa: focus on patient teaching.
    Sasak C; Giordano E
    ANNA J; 1990 Apr; 17(2):188-9. PubMed ID: 2327804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case study of the anemic patient: epoetin alfa--focus on inflammation.
    Fuchs J
    ANNA J; 1994 Feb; 21(1):78-81. PubMed ID: 8141637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
    Lundin AP
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on the improvement of quality of life with epoetin alfa therapy.
    Lundin AP; Delano BG; Quinn-Cefaro R
    Pharmacotherapy; 1990; 10(2 ( Pt 2)):22S-26S. PubMed ID: 2345708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.